Repeated PPV effective for macular holes

Article

Repeated pars plana vitrectomy, with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the Journal of Retinal and Vitreous Diseases.

Repeated pars plana vitrectomy (PPV), with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the journal Retina.

A retrospective study, led by Dr E. Moissesiev, Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, involved 29 eyes that underwent repeated pars plana vitrectomy and limiting membrane peeling. The group obtained demographic information, visual acuity before the first and second operations, MH diameter before and after both surgical procedures and throughout the follow-up. Additional details retrieved included surgical details, time between surgeries, final visual acuity and the occurrence of any complications.

Reoperation caused the closure of persistent MH in 68.9% of the eyes and final visual acuity significantly improved, compared to results from before the second surgery.

In total, 62% of patients gained >2 lines after reoperation, with shorter interoperative time and smaller initial MH diameter significantly correlating with better visual prognosis.

The abstract can be viewed here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.